einstein (São Paulo). 06/Apr/2018;16(1):eAO4036.

Is quality of life associated with compliance to pharmacoterapy in patients with chronic kidney disease undergoing maintenance hemodialysis?

Keila Batista Alves, Nathália Vital Guilarducci, Thiago dos Reis Santos, André Oliveira Baldoni, Alba Otoni, Sérgio Wyton Lima Pinto, Camila Zanette, Cristina Sanches

DOI: 10.1590/S1679-45082018AO4036

ABSTRACT

Objective

To analyzed the association of quality of life and compliance to drug treatment in chronic kidney disease patients.

Methods

The Short Form Health Survey was used to evaluate the quality of life of these patients, and the therapeutic complexity index was verified. The Morisky-Green test and the Brief Medication Questionnaire were applied to check compliance to drug therapy.

Results

A total of 197 patients were included. The Morisky-Green test and Brief Medication Questionnaire showed that most patients had low compliance to treatment (50.3% and 80.6%, respectively). Compliance was highly associated with gender (male) and slightly associated with complexity of therapy, mental health, and social aspects.

Conclusion

We observed a slight association between compliance to pharmacotherapy and quality of life and complexity of therapy, and a strong association with gender.

Is quality of life associated with compliance to pharmacoterapy in patients with chronic kidney disease undergoing maintenance hemodialysis?

Comments